Clinical Trial Update: Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating amphotericin B for visceral leishmaniasis in Brazilian children has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

Sponsor: University of Brasilia | Conditions: Visceral Leishmaniasis | Phase 4 | Status: COMPLETED